Yi JH - Search Results

1

Bendamustine Plus Rituximab for Mantle Cell Lymphoma: A Korean, Multicenter Retrospective Analysis.

Yi JH, Kim SJ, Lee JO, Lee GW, Kwak JY, Eom HS, Jo JC, Choi YS, Oh SY, Kim WS. Yi JH, et al. Anticancer Res. 2022 Dec;42(12):6083-6089. doi: 10.21873/anticanres.16120. Anticancer Res. 2022. PMID: 36456154

2

Rituximab-induced acute thrombocytopenia: a case report and review of the literature.

Yi JH, Kim SJ, Ahn HK, Lee SJ, Chang MH, Kim WS. Yi JH, et al. Med Oncol. 2009;26(1):45-8. doi: 10.1007/s12032-008-9079-6. Epub 2008 Jun 10. Med Oncol. 2009. PMID: 18543133

3

18F-FDG uptake and its clinical relevance in primary gastric lymphoma.

Yi JH, Kim SJ, Choi JY, Ko YH, Kim BT, Kim WS. Yi JH, et al. Hematol Oncol. 2010 Jun;28(2):57-61. doi: 10.1002/hon.905. Hematol Oncol. 2010. PMID: 19593742

4

Improved treatment outcome of primary mediastinal large B-cell lymphoma after introduction of rituximab in Korean patients.

Ahn HK, Kim SJ, Yun J, Yi JH, Kim JH, Won YW, Kim K, Ko YH, Kim WS. Ahn HK, et al. Among authors: yi jh. Int J Hematol. 2010 Apr;91(3):456-63. doi: 10.1007/s12185-010-0536-6. Epub 2010 Mar 3. Int J Hematol. 2010. PMID: 20198460

5

Treatment of patients with refractory diffuse large B-cell lymphoma or mantle cell lymphoma with alemtuzumab, alone or in combination with cytotoxic chemotherapy.

Yi JH, Kim SJ, Ko YH, Kim WS. Yi JH, et al. Leuk Lymphoma. 2011 Feb;52(2):317-20. doi: 10.3109/10428194.2010.529203. Epub 2010 Nov 11. Leuk Lymphoma. 2011. PMID: 21067447 No abstract available.

6

Dacarbazine-based chemotherapy as first-line treatment in noncutaneous metastatic melanoma: multicenter, retrospective analysis in Asia.

Yi JH, Yi SY, Lee HR, Lee SI, Lim DH, Kim JH, Park KW, Lee J. Yi JH, et al. Among authors: yi sy. Melanoma Res. 2011 Jun;21(3):223-7. doi: 10.1097/CMR.0b013e3283457743. Melanoma Res. 2011. PMID: 21471822

7

Randomised phase II trial of docetaxel and sunitinib in patients with metastatic gastric cancer who were previously treated with fluoropyrimidine and platinum.

Yi JH, Lee J, Lee J, Park SH, Park JO, Yim DS, Park YS, Lim HY, Kang WK. Yi JH, et al. Br J Cancer. 2012 Apr 24;106(9):1469-74. doi: 10.1038/bjc.2012.100. Epub 2012 Mar 29. Br J Cancer. 2012. PMID: 22460270 Free PMC article. Clinical Trial.

8

Effects of single nucleotide polymorphisms on treatment outcomes and toxicity in patients treated with sunitinib.

Maeng CH, Yi JH, Lee J, Hong JY, Choi MK, Jung HA, Park JO, Park SH, Park YS, Kang WK, Lim HY. Maeng CH, et al. Among authors: yi jh. Anticancer Res. 2013 Oct;33(10):4619-26. Anticancer Res. 2013. PMID: 24123039

9

A Retrospective Analysis for Patients with HER2-Positive Gastric Cancer Who Were Treated with Trastuzumab-Based Chemotherapy: In the Perspectives of Ethnicity and Histology.

Yi JH, Kang JH, Hwang IG, Ahn HK, Baek HJ, Lee SI, Lim DH, Won YW, Ji JH, Kim HS, Rha SY, Oh SY, Lee KE, Lim T, Maeng CH, Kim MJ, Kim ST, Lee J, Park JO, Park YS, Lim HY, Kang WK, Park SH. Yi JH, et al. Cancer Res Treat. 2016 Apr;48(2):553-60. doi: 10.4143/crt.2015.155. Epub 2015 Aug 10. Cancer Res Treat. 2016. PMID: 26323641 Free PMC article.

10

Intrinsic resistance to sunitinib in patients with metastatic renal cell carcinoma.

Lim SH, Hwang IG, Ji JH, Oh SY, Yi JH, Lim DH, Lim HY, Lee SJ, Park SH. Lim SH, et al. Among authors: yi jh. Asia Pac J Clin Oncol. 2017 Feb;13(1):61-67. doi: 10.1111/ajco.12465. Epub 2016 Mar 31. Asia Pac J Clin Oncol. 2017. PMID: 27030134

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

384 results

Search Page